XML 18 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   144,220,986      
Beginning balance at Dec. 31, 2024 $ 1,229,684 $ 1,768 $ 2,764,880 $ 2,020 $ (1,538,984)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances under equity incentive plans (in shares)   113,792      
Issuances under equity incentive plans 595 $ 1 594    
Vesting of restricted stock units (in shares)   916,480      
Vesting of restricted stock units 0 $ 9 (9)    
Stock-based compensation 25,360   25,360    
Net loss (132,970)       (132,970)
Other comprehensive income (loss) 17     17  
Ending balance (in shares) at Mar. 31, 2025   145,251,258      
Ending balance at Mar. 31, 2025 $ 1,122,686 $ 1,778 2,790,825 2,037 (1,671,954)
Beginning balance (in shares) at Dec. 31, 2025 156,182,177 156,182,177      
Beginning balance at Dec. 31, 2025 $ 1,013,761 $ 1,888 3,062,715 682 (2,051,524)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of issuance cost (in shares)   746,468      
Issuance of common stock, net of issuance cost 12,366 $ 8 12,358    
Issuances under equity incentive plans (in shares)   536,720      
Issuances under equity incentive plans 6,695 $ 5 6,690    
Vesting of restricted stock units (in shares)   1,190,953      
Vesting of restricted stock units 0 $ 12 (12)    
Stock-based compensation 23,087   23,087    
Net loss (128,447)       (128,447)
Other comprehensive income (loss) $ (1,364)     (1,364)  
Ending balance (in shares) at Mar. 31, 2026 158,656,318 158,656,318      
Ending balance at Mar. 31, 2026 $ 926,098 $ 1,913 $ 3,104,838 $ (682) $ (2,179,971)